B Cell News and Research

RSS

$Study reveals obesity's impact on muscle structure in heart failure with preserved ejection fraction$

Study reveals obesity's impact on muscle structure in heart failure with preserved ejection fraction

A new small study led by Johns Hopkins Medicine researchers and published July 25th in the journal Nature Cardiovascular Research has revealed the impact of obesity on muscle structure in patients having a form of heart failure called heart failure with a preserved ejection fraction (HFpEF).

1 Aug 2024

New lab technique captures aging effects in Alzheimer's disease development

Researchers at Washington University School of Medicine in St. Louis have developed a way to capture the effects of aging in the development of Alzheimer's disease.

1 Aug 2024

Fish oil may benefit older adults with genetic Alzheimer's risk

A clinical trial at Oregon Health & Science University suggests that a subset of older adults with a genetic predisposition to Alzheimer's disease may benefit from fish oil supplements.

1 Aug 2024

Novel electrical impedance technique enhances drug testing for cardiac safety

When developing new drugs, understanding their effects on ion channels in the body, such as the human ether-a-go-go-related gene (hERG) ion channel found in neurons and heart muscle cells, is critical.

1 Aug 2024

Study reveals how geographic origins influence tuberculosis infection risk

For some forms of tuberculosis, the chances that an exposed person will get infected depend on whether the individual and the bacteria share a hometown, according to a new study comparing how different strains move through mixed populations in cosmopolitan cities.

1 Aug 2024

The complex relationship between diet nutrition and cancer

The existing knowledge on the beneficial and detrimental effects of dietary patterns and nutritional supplements on cancer risk.

1 Aug 2024

Single-cell RNA sequencing sheds light on stroke-induced brain damage

Strokes lead to irreversible damage to the brain and are one of the most common causes of dependency or death.

1 Aug 2024

Novel anti-tuberculosis compound targets bacterial membrane protein

Researchers from Heinrich Heine University Düsseldorf (HHU) and the University of Duisburg-Essen (UDE) have together succeeded in identifying and synthesizing a group of molecules that can act against the cause of tuberculosis in a new way. In the scientific journal Cell Chemical Biology, they describe that the so-called callyaerins act against the infectious disease by employing a fundamentally different mechanism compared to antibiotic agents used to date.

1 Aug 2024

UC San Diego develops AI tool for rapid, low-cost detection of genomic alterations in cancer

A new generation of artificial intelligence (AI) tools designed to allow rapid, low-cost detection of clinically actionable genomic alterations directly from tumor biopsy slides has been developed by a team led by engineers and medical researchers at University of California San Diego.

1 Aug 2024

Anticancer drugs show promise in reducing Alzheimer's dementia risk

Study finds anticancer drugs, specifically antimetabolites and molecular targeted therapies, may reduce the risk of Alzheimer's type dementia but not vascular dementia.

1 Aug 2024

AI unlocks potential of antimicrobial peptides for new antibiotics

In a hopeful sign for demand for more safe, effective antibiotics for humans, researchers at The University of Texas at Austin have leveraged artificial intelligence to develop a new drug that already is showing promise in animal trials.

1 Aug 2024

AI reprograms glioblastoma cells into dendritic cells for cancer immunotherapy

In an innovative new study of glioblastoma, scientists used artificial intelligence (AI) to reprogram cancer cells, converting them into dendritic cells (DCs), which can identify cancer cells and direct other immune cells to kill them.

31 Jul 2024

Salk Institute receives CIRM funding for stem cell research on aging and neurodegeneration

The Salk Institute was awarded $3.6 million by the California Institute for Regenerative Medicine (CIRM), one of the world's largest institutions dedicated to regenerative medicine.

31 Jul 2024

FDA clears UAB startup's TIX100 for clinical trials

The University of Alabama at Birmingham startup TIXiMED, Inc., has obtained clearance from the United States Food and Drug Administration to proceed to clinical trials under an Investigational New Drug for TIX100, its novel oral Type 1 diabetes drug.

31 Jul 2024

Study reveals serotonin's role in ependymoma tumor growth

Do neurons play a role in brain tumor growth and development? Scientists at St. Jude Children's Research Hospital and Baylor College of Medicine have evidence showing that, for childhood ependymomas, they do.

31 Jul 2024

Powerful visualization technologies offer new insight into understanding muscle contraction in humans

The connections between the nervous system and muscles develop differently across the kingdom of life.

31 Jul 2024

New method efficiently converts stem cells to endothelial cells for cardiovascular research

The innermost layer of blood vessels is formed by endothelial cells, which in turn play a role in the development of diseases of the cardiovascular system.

31 Jul 2024

Commonly used anesthetic drug can restore the function of ion channel linked to epilepsy

Mutated variants of a particular ion channel cause difficult-to-treat epilepsy. A study published in the journal Nature now shows that a commonly used anesthetic drug, propofol, can restore the function of this ion channel.

31 Jul 2024

Discovery of potent immune cells near glioblastomas opens new avenues for treatment

Glioblastomas are highly aggressive, usually incurable brain tumors. If all therapeutic options are exhausted, patients have an average life expectancy of less than two years.

31 Jul 2024

Neurodivergent children face higher risk of chronic disabling fatigue by 18, study finds

Neurodivergent traits in childhood double the risk of chronic disabling fatigue by age 18, with inflammation playing a significant mediating role. This highlights the importance of addressing inflammatory markers in managing the health of neurodivergent individuals.

31 Jul 2024

B Cell News and Research

Study reveals obesity's impact on muscle structure in heart failure with preserved ejection fraction

New lab technique captures aging effects in Alzheimer's disease development

Fish oil may benefit older adults with genetic Alzheimer's risk

Novel electrical impedance technique enhances drug testing for cardiac safety

Study reveals how geographic origins influence tuberculosis infection risk

The complex relationship between diet nutrition and cancer

Single-cell RNA sequencing sheds light on stroke-induced brain damage

Novel anti-tuberculosis compound targets bacterial membrane protein

UC San Diego develops AI tool for rapid, low-cost detection of genomic alterations in cancer

Anticancer drugs show promise in reducing Alzheimer's dementia risk

AI unlocks potential of antimicrobial peptides for new antibiotics

AI reprograms glioblastoma cells into dendritic cells for cancer immunotherapy

Salk Institute receives CIRM funding for stem cell research on aging and neurodegeneration

FDA clears UAB startup's TIX100 for clinical trials

Study reveals serotonin's role in ependymoma tumor growth

Powerful visualization technologies offer new insight into understanding muscle contraction in humans

New method efficiently converts stem cells to endothelial cells for cardiovascular research

Commonly used anesthetic drug can restore the function of ion channel linked to epilepsy

Discovery of potent immune cells near glioblastomas opens new avenues for treatment

Neurodivergent children face higher risk of chronic disabling fatigue by 18, study finds

Using single B cell screening to boost antibody discovery eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News